Skip to main content
. Author manuscript; available in PMC: 2016 Oct 21.
Published in final edited form as: Oncogene. 2016 Apr 4;35(42):5480–5488. doi: 10.1038/onc.2016.91

Figure 4. Re-expression of endogenous miR-124 correlates with repressed SMOX expression.

Figure 4

AGS cells were treated with 5-azacytidine (5-azaC) every 48 h (3 treatments total). RNA expression levels were quantified using qRT-PCR with primers specific to miR-124 (A) or SMOX (B). miR-124 transcript levels are relative to U6, and SMOX levels are relative to GAPDH. Columns indicate the means (n = 3) with error bars indicating SEM. In C, expression levels from the individual experiments in A and B were used for regression analysis. Spearman’s rank correlation was used to calculate r and p values. SMOX activity (D) following 5-azaC treatment was measured as pmol H2O2/mg protein/minute (n = 3 independent experiments measured in triplicate; error bars = SEM; *p < 0.01; ***p < 0.001).